TLR9 and IRF3 cooperate to induce a systemic inflammatory response in mice injected with liposome:DNA

Molecular Therapy

Volumn 18, Issue 4, 2010, Pages 775-784

  Walker, Wendy E ^a   Booth, Carmen J ^a   Goldstein, Daniel R ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GLYCOPROTEIN P 15095; INTERFERON REGULATORY FACTOR 3; LIPOSOME; PLASMID DNA; TOLL LIKE RECEPTOR 9;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; ENZYME BLOOD LEVEL; GENE THERAPY; GENE VECTOR; HYPOTHERMIA; HYPOTHESIS; IN VITRO STUDY; KNOCKOUT MOUSE; MORTALITY; MOUSE; NONHUMAN; ORGAN INJURY; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SURVIVAL; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

MUS;

EID: 77950518417     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2010.1     Document Type: Article

References (50)

1. Scheule, RK, St George, JA, Bagley, RG, Marshall, J, Kaplan, JM, Akita, GY et al. (1997). Basis of pulmonary toxicity associated with cationic lipid-mediated gene transfer to the mammalian lung. Hum Gene Ther 8: 689-707.
2. McMahon, JM, Wells, KE, Bamfo, JE, Cartwright, MA and Wells, DJ (1998). Infammatory responses following direct injection of plasmid DNA into skeletal muscle. Gene Ther 5: 1283-1290.
3. Freimark, BD, Blezinger, H P, Florack, VJ, Nordstrom, JL, Long, SD, Deshpande, DS et al. (1998). Cationic lipids enhance cytokine and cell infux levels in the lung following administration of plasmid: cationic lipid complexes. J Immunol 160: 4580-4586.
4. Yew, NS, Wang, KX, Przybylska, M, Bagley, RG, Stedman, M, Marshall, J et al. (1999). Contribution of plasmid DNA to infammation in the lung after administration of cationic lipid:pDNA complexes. Hum Gene Ther 10: 223-234. (Pubitemid 29070636)
5. Li, S, Wu, SP, Whitmore, M, Loeffert, EJ, Wang, L, Watkins, SC et al. (1999). Effect of immune response on gene transfer to the lung via systemic administration of cationic lipidic vectors. Am J Physiol 276(5 Pt 1): L796-L804. (Pubitemid 29249633)
6. Alton, EW, Stern, M, Farley, R, Jaffe, A, Chadwick, SL, Phillips, J et al. (1999). Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fbrosis: a double-blind placebo-controlled trial. Lancet 353: 947-954. (Pubitemid 29132602)
7. Tan, Y, Li, S, Pitt, BR and Huang, L (1999). The inhibitory role of CpG immunostimulatory motifs in cationic lipid vector-mediated transgene expression in vivo. Hum Gene Ther 10: 2153-2161. (Pubitemid 29416295)
8. Norman, J, Denham, W, Denham, D, Yang, J, Carter, G, Abouhamze, A et al. (2000). Liposome-mediated, nonviral gene transfer induces a systemic infammatory response which can exacerbate pre-existing infammation. Gene Ther 7: 1425-1430. (Pubitemid 30662250)
9. Schnell, MA, Zhang, Y, Tazelaar, J, Gao, GP, Yu, QC, Qian, R et al. (2001). Activation of innate immunity in nonhuman primates following intraportal administration of adenoviral vectors. Mol Ther 3(5 Pt 1): 708-722. (Pubitemid 32509868)
10. Zhang, Y, Chirmule, N, Gao, GP, Qian, R, Croyle, M, Joshi, B et al. (2001). Acute cytokine response to systemic adenoviral vectors in mice is mediated by dendritic cells and macrophages. Mol Ther 3(5 Pt 1): 697-707. (Pubitemid 32509867)
11. Loisel, S, Le Gall, C, Doucet, L, Ferec, C and Floch, V (2001). Contribution of plasmid DNA to hepatotoxicity after systemic administration of lipoplexes. Hum Gene Ther 12: 685-696. (Pubitemid 32506946)
12. Sakurai, F, Terada, T, Yasuda, K, Yamashita, F, Takakura, Y and Hashida, M (2002). The role of tissue macrophages in the induction of proinfammatory cytokine production following intravenous injection of lipoplexes. Gene Ther 9: 1120-1126.
13. Raper, SE, Chirmule, N, Lee, FS, Wivel, NA, Bagg, A, Gao, GP et al. (2003). Fatal systemic infammatory response syndrome in a ornithine transcarbamylase defcient patient following adenoviral gene transfer. Mol Genet Metab 80: 148-158. (Pubitemid 37272241)
14. Sakurai, H, Sakurai, F, Kawabata, K, Sasaki, T, Koizumi, N, Huang, H et al. (2007). Comparison of gene expression effciency and innate immune response induced by Ad vector and lipoplex. J Control Release 117: 430-437. (Pubitemid 46216585)
15. Sakurai, H, Kawabata, K, Sakurai, F, Nakagawa, S and Mizuguchi, H (2008). Innate immune response induced by gene delivery vectors. Int J Pharm 354: 9-15. (Pubitemid 351400322)
16. Ezekowitz, RAB and Hoffmann, JA (1996). Innate immunity. Curr Opin Immunol 8: 1-2.
17. Takeda, K and Akira, S (2005). Toll-like receptors in innate immunity. Int Immunol 17: 1-14.
18. Krieg, AM (1999). Direct immunologic activities of CpG DNA and implications for gene therapy. J Gene Med 1: 56-63.
19. Krieg, AM (2002). CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol 20: 709-760.
20. Sivori, S, Falco, M, Della Chiesa, M, Carlomagno, S, Vitale, M, Moretta, L et al. (2004). CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells. Proc Natl Acad Sci USA 101: 10116-10121. (Pubitemid 38891204)
21. Schmidt, KN, Leung, B, Kwong, M, Zarember, KA, Satyal, S, Navas, TA et al. (2004). APC-independent activation of NK cells by the Toll-like receptor 3 agonist double-stranded RNA. J Immunol 172: 138-143. (Pubitemid 38020465)
22. Honda, K and Taniguchi, T (2006). IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immunol 6: 644-658. (Pubitemid 44298214)
23. Iwamura, T, Yoneyama, M, Yamaguchi, K, Suhara, W, Mori, W, Shiota, K et al. (2001). Induction of IRF-3/-7 kinase and NF-kappaB in response to double-stranded RNA and virus infection: common and unique pathways. Genes Cells 6: 375-388. (Pubitemid 32401282)
24. Hiscott, J (2007). Triggering the innate antiviral response through IRF-3 activation. J Biol Chem 282: 15325-15329. (Pubitemid 47093257)
25. Takeuchi, O and Akira, S (2008). MDA5/RIG-I and virus recognition. Curr Opin Immunol 20: 17-22.
26. Yoneyama, M, Onomoto, K and Fujita, T (2008). Cytoplasmic recognition of RNA. Adv Drug Deliv Rev 60: 841-846.
27. Ishii, KJ, Coban, C, Kato, H, Takahashi, K, Torii, Y, Takeshita, F et al. (2006). A Toll-like receptor-independent antiviral response induced by double-stranded B-form DNA. Nat Immunol 7: 40-48. (Pubitemid 41823867)
28. Stetson, DB and Medzhitov, R (2006). Recognition of cytosolic DNA activates an IRF3-dependent innate immune response. Immunity 24: 93-103. (Pubitemid 43077203)
29. Takaoka, A, Wang, Z, Choi, MK, Yanai, H, Negishi, H, Ban, T et al. (2007). DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 448: 501-505. (Pubitemid 47123520)
30. Wang, Z, Choi, MK, Ban, T, Yanai, H, Negishi, H, Lu, Y et al. (2008). Regulation of innate immune responses by DAI (DLM-1/ZBP1) and other DNA-sensing molecules. Proc Natl Acad Sci USA 105: 5477-5482. (Pubitemid 351753888)
31. Chiu, YH, Macmillan, JB and Chen, ZJ (2009). RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway. Cell 138: 576-591.
32. Ablasser, A, Bauernfeind, F, Hartmann, G, Latz, E, Fitzgerald, KA and Hornung, V (2009). RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III-transcribed RNA intermediate. Nat Immunol 10: 1065-1072.
33. Ishii, KJ, Kawagoe, T, Koyama, S, Matsui, K, Kumar, H, Kawai, T et al. (2008). TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines. Nature 451: 725-729. (Pubitemid 351220566)
34. Pinsky, MR (2007). Sepsis and multiple organ failure. Contrib Nephrol 156: 47-63.
35. Rittirsch, D, Flierl, MA and Ward, PA (2008). Harmful molecular mechanisms in sepsis. Nat Rev Immunol 8: 776-787.
36. McLachlan, G, Stevenson, BJ, Davidson, DJ and Porteous, DJ (2000). Bacterial DNA is implicated in the infammatory response to delivery of DNA/DOTAP to mouse lungs. Gene Ther 7: 384-392. (Pubitemid 30156550)
37. Yew, NS, Zhao, H, Wu, IH, Song, A, Tousignant, JD, Przybylska, M et al. (2000). Reduced infammatory response to plasmid DNA vectors by elimination and inhibition of immunostimulatory CpG motifs. Mol Ther 1: 255-262.
38. Zhao, H, Hemmi, H, Akira, S, Cheng, SH, Scheule, RK and Yew, NS (2004). Contribution of Toll-like receptor 9 signaling to the acute infammatory response to nonviral vectors. Mol Ther 9: 241-248. (Pubitemid 38256550)
39. Hodges, BL, Taylor, KM, Joseph, MF, Bourgeois, SA and Scheule, RK (2004). Long-term transgene expression from plasmid DNA gene therapy vectors is negatively affected by CpG dinucleotides. Mol Ther 10: 269-278.
40. Hyde, SC, Pringle, IA, Abdullah, S, Lawton, AE, Davies, LA, Varathalingam, A et al. (2008). CpG-free plasmids confer reduced infammation and sustained pulmonary gene expression. Nat Biotechnol 26: 549-551. (Pubitemid 351668040)
41. Yoneyama, M, Suhara, W and Fujita, T (2002). Control of IRF-3 activation by phosphorylation. J Interferon Cytokine Res 22: 73-76. (Pubitemid 34161284)
42. Gruneich, JA, Price, A, Zhu, J and Diamond, SL (2004). Cationic corticosteroid for nonviral gene delivery. Gene Ther 11: 668-674. (Pubitemid 38519274)
43. Qin, L, Ding, Y, Pahud, DR, Chang, E, Imperiale, MJ and Bromberg, JS (1997). Promoter attenuation in gene therapy: interferon-gamma and tumor necrosis factor-alpha inhibit transgene expression. Hum Gene Ther 8: 2019-2029. (Pubitemid 28072573)
44. Zuniga, EI, Hahm, B and Oldstone, MB (2007). Type I interferon during viral infections: multiple triggers for a multifunctional mediator. Curr Top Microbiol Immunol 316: 337-357.
45. Rothlin, CV, Ghosh, S, Zuniga, EI, Oldstone, MB and Lemke, G (2007). TAM receptors are pleiotropic inhibitors of the innate immune response. Cell 131: 1124-1136. (Pubitemid 350235020)
46. Ma, X, Chow, JM, Gri, G, Carra, G, Gerosa, F, Wolf, SF et al. (1996). The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells. J Exp Med 183: 147-157. (Pubitemid 26028754)
47. Leenen, PJ, Radosevic, K, Voerman, JS, Salomon, B, van Rooijen, N, Klatzmann, D et al. (1998). Heterogeneity of mouse spleen dendritic cells: in vivo phagocytic activity, expression of macrophage markers, and subpopulation turnover. J Immunol 160: 2166-2173. (Pubitemid 28119895)
48. Nikolic, T, Geutskens, SB, van Rooijen, N, Drexhage, HA and Leenen, PJ (2005). Dendritic cells and macrophages are essential for the retention of lymphocytes in (peri)-insulitis of the nonobese diabetic mouse: a phagocyte depletion study. Lab Invest 85: 487-501. (Pubitemid 40523941)
49. Walker, WE and Goldstein, DR (2007). Neonatal B cells suppress innate toll-like receptor immune responses and modulate alloimmunity. J Immunol 179: 1700-1710.
50. Walker, WE, Nasr, IW, Camirand, G, Tesar, BM, Booth, CJ and Goldstein, DR (2006). Absence of innate MyD88 signaling promotes inducible allograft acceptance. J Immunol 177: 5307-5316. (Pubitemid 44527603)